{"id":99,"date":"2018-07-23T15:46:05","date_gmt":"2018-07-23T19:46:05","guid":{"rendered":"https:\/\/www.secarbitrationlawyer.com\/?p=99"},"modified":"2018-07-23T15:46:05","modified_gmt":"2018-07-23T19:46:05","slug":"shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/","title":{"rendered":"SHAREHOLDER ALERT: Silver Law Group Notifies Investors of Class Action Lawsuit Against Akers Biosciences, Inc. (Nasdaq: AKER)"},"content":{"rendered":"

Silver Law Group, a securities and investment fraud law firm announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc. (Nasdaq: AKER) (\u201cAkers\u201d or the \u201cCompany\u201d) securities during the period between May 15, 2017 and June 5, 2018, inclusive (the \u201cClass Period\u201d).\u00a0 Investors who wish to serve as a lead plaintiff in the litigation have until August 13, 2018 to seek appointment as lead plaintiff.<\/p>\n

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants\u2019 failure to disclose during the Class Period that Akers was improperly recognizing revenue for the fiscal year ended December 31, 2017, and it downplayed weaknesses in its internal controls over financial reporting.<\/p>\n

According to the complaint, following a May 21, 2018 filing disclosing the Company\u2019s continuing review of certain revenue recognition items, a May 29, 2018 press release announcing that a director had resigned, and a June 5, 2018 filing stating the previously filed Form 8-K made false statements regarding the director, the value of Akers shares declined significantly.<\/p>\n

Continue reading \u203a<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Silver Law Group, a securities and investment fraud law firm announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc. (Nasdaq: AKER) (\u201cAkers\u201d or the \u201cCompany\u201d) securities during the period between May 15, 2017 and June […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602],"tags":[196,1671,1672,1673],"class_list":["post-99","post","type-post","status-publish","format-standard","hentry","category-class-action","tag-aegis-capital-corp","tag-akers-biosciences-inc","tag-akers-class-action","tag-scott-silver-akers-biosciences"],"yoast_head":"\nSHAREHOLDER ALERT: Silver Law Group Notifies Investors of Class Action Lawsuit Against Akers Biosciences, Inc. (Nasdaq: AKER) — Securities Arbitration Lawyers Blog — July 23, 2018<\/title>\n<meta name=\"description\" content=\"Silver Law Group, a securities and investment fraud law firm announces that a class action lawsuit has been commenced in the United States District Court — July 23, 2018\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"SHAREHOLDER ALERT: Silver Law Group Notifies Investors of Class Action Lawsuit Against Akers Biosciences, Inc. (Nasdaq: AKER) — Securities Arbitration Lawyers Blog — July 23, 2018\" \/>\n<meta name=\"twitter:description\" content=\"Silver Law Group, a securities and investment fraud law firm announces that a class action lawsuit has been commenced in the United States District Court — July 23, 2018\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Silver Law Group Notifies Investors of Class Action Lawsuit Against Akers Biosciences, Inc. (Nasdaq: AKER) — Securities Arbitration Lawyers Blog — July 23, 2018","description":"Silver Law Group, a securities and investment fraud law firm announces that a class action lawsuit has been commenced in the United States District Court — July 23, 2018","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/","twitter_card":"summary_large_image","twitter_title":"SHAREHOLDER ALERT: Silver Law Group Notifies Investors of Class Action Lawsuit Against Akers Biosciences, Inc. (Nasdaq: AKER) — Securities Arbitration Lawyers Blog — July 23, 2018","twitter_description":"Silver Law Group, a securities and investment fraud law firm announces that a class action lawsuit has been commenced in the United States District Court — July 23, 2018","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/#article","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/"},"author":{"name":"Silver Law Group","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"headline":"SHAREHOLDER ALERT: Silver Law Group Notifies Investors of Class Action Lawsuit Against Akers Biosciences, Inc. (Nasdaq: AKER)","datePublished":"2018-07-23T19:46:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/"},"wordCount":407,"keywords":["Aegis Capital Corp.","Akers Biosciences Inc.","akers class action","scott silver Akers Biosciences"],"articleSection":["Class Action"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/","url":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/","name":"SHAREHOLDER ALERT: Silver Law Group Notifies Investors of Class Action Lawsuit Against Akers Biosciences, Inc. (Nasdaq: AKER) — Securities Arbitration Lawyers Blog — July 23, 2018","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"datePublished":"2018-07-23T19:46:05+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"Silver Law Group, a securities and investment fraud law firm announces that a class action lawsuit has been commenced in the United States District Court — July 23, 2018","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/shareholder-alert-silver-law-group-notifies-investors-of-class-action-lawsuit-against-akers-biosciences-inc-nasdaq-aker\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Silver Law Group Notifies Investors of Class Action Lawsuit Against Akers Biosciences, Inc. (Nasdaq: AKER)"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/99","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=99"}],"version-history":[{"count":0,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/99\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=99"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=99"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=99"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}